Editor's Choice
Latest Update
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in...
> read more
Editor's Choice
Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID
Innovative, easy-to-use molecular diagnostics workflow reduces complexity and costs for labslooking to expand newborn screening capabilities
Certest completes the expansion of its new facilities
The construction of the two new buildings has represented an investment of 22 million euros
Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders
New clinical data from Octapharma's haematology portfolio will be presented during the scientific program at the 65th American Society of Hematology (ASH) Meeting and Exposition, which...
Bracco Announces Long-Term Strategic Partnership with ulrich medical for Syringeless Magnetic Resonance Injectors
The private label arrangement will bring a new syringeless magnetic resonance (MR) injector to the U.S. 510(k) premarket notification has been submitted to the U.S. Food and...
Attend the Healthcare Innovation Summit Africa 2023
As technology continues to transform and disrupt every sector, the health sector is no exception. Digital innovation is having a tremendous impact on the healthcare industry from the...
deepc Establishes MONAI Compatibility, Strengthening Its Commitment to Open-Source Collaboration and Global Healthcare Transformation
deepc, a leading MedTech company, aligns strategically with MONAI, the Medical Open Network for Artificial Intelligence. A community-driven open-source framework co-founded by NVIDIA...
DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia
DxVx announces today that it will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford Vacmedix(OVM) by license-in agreement and develop further with its own...
Trillium Health Partners to become first in Canada to deploy AI in diagnostic imaging using Sectra Amplifier Services
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) helps Trillium Health Partners (THP) in Canada adopt AI technology with new AI-as-a-service agreement...
QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolation
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its sample technologies portfolio with the introduction of two new products aimed at...
Medica And Compamed: Medical Technology Business Benefits From The Strong International Visitor Response
High decision-maker ratio, unique variety of new products and a top-class supporting program
MEDICA and COMPAMED: Medical technology business is profiting from strong appeal to international visitors
High proportion of decision-makers, unique variety of innovations and a high-calibre accompanying programme
Roche’s MS test scores FDA breakthrough device designation
Roche’s Elecsys neurofilament light chain (NfL) test is used for detecting disease activity in multiple sclerosis.
QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customers
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of three new kits for use on its QIAcuity systems and a major new software update designed to expand...
Deep Bio Joins CancerX to Revolutionize Cancer Diagnosis and Prognosis with AI Expertise
Deep Bio, a leading AI healthcare company specializing in deep learning and cancer pathology, is proud to announce its participation in the groundbreaking CancerX initiative,...
Incheon National University Scientists Develop New Hydrogels for Wound Management
By leveraging the power of oxygen, these gelatin patches can act as effective tissue adhesives that accelerate the healing of wounds
Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023
Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for chest radiograph reporting efficiency and breast cancer risk assessment
Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development
Company to use funds awarded by the Bill & Melinda Gates Foundation toward the tuberculosis test for its Co-Dx™ PCR platform
QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Myriad Genetics (NASDAQ: MYGN) today announced a new master collaboration agreement to develop companion diagnostic tests in...
Canon Medical integrates sports, AI and diagnostics in new facility
Canon Medical's new diagnostic and sports centre in Sheffield is aimed in part at helping to expand the company's AI capabilities.